Colorectal cancer screening participation: A systematic review

European Journal of Public Health

Volumn 26, Issue 1, 2016, Pages 158-168

  Wools, A ^a   Dapper, E A ^a   Leeuw, J R J De ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ATTITUDE TO HEALTH; BODY MASS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; PATIENT ATTITUDE; PSYCHOLOGY; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; BODY MASS INDEX; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84962004165     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckv148     Document Type: Article

References (107)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-86.
2. Centraal Bureau voor de Statistiek Available at: http://www.cbs.nl (9 July 2014, date last accessed).
3. Integrale kankercentra Available at: http://ikcnet/n (9 July 2014, date last accessed).
4. Heresbach D, Manfredi S, D'halluin PN, et al. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006;18:427-33.
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
6. National Insitute of Public Health and the Environment Ministry of Health, Welfare and Sport. Bowel Cancer Screening Programme. Available at: http://www.rivm.nl/en/Topics/B/Bowel-cancer-screening-programme. (9 July 2014, date last accessed).
7. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60.
8. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer 2010;116:4872-81.
9. Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: A review. Prev Med 2004;38:536-50.
10. Vernon SW. Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997;89:1406-22.
11. Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviours among average-risk older adults in the United States. Cancer Causes Control 2008;19:339-59.
12. Ko CW, Kreuter W, Baldwin L-M. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol 2005;5.
13. Shih YC, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff 2006;25:1153-62.
14. Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med 1995;41:365-74.
15. von Wagner C, Baio G, Raine R, et al. Inequalities in colorectal cancer screening uptake: results from the first 2.6 million invitations in the organized screening program in the U.K. Cancer Prev Res 2010;3.
16. Yager SS, Chen L, Cheung WY Sex-based disparities in colorectal cancer screening. Am J Clin Oncol 2013.
17. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-94.
18. Brounts LR, Lehmann RK, Lesperance KE, et al. Improved rates of colorectal cancer screening in an equal access population. Am J Surg 2009;197:609-13.
19. Afable-Munsuz A, Liang SY, Ponce NA, Walsh JM. Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med 2009;24:963-70.
20. Berkowitz Z, Hawkins NA, Peipins LA, et al. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc 2008;56:307-14.
21. Ananthakrishnan AN, Schellhase KG, Sparapani RA, et al. Disparities in colon cancer screening in the Medicare population. Arch Intern Med 2007 12;167:258-64.
22. Ata A, Elzey JD, Insaf TZ, et al. Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations. Cancer Detect Prev 2006;30:134-43.
23. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med 2003;36:659-68.
24. Christie JA, Jandorf L, Itzkowitz SH, et al. Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Gastroenterology 2009;136:A337-8.
25. Crawford ND, Jones CP, Richardson LC. Understanding racial and ethnic disparities in colorectal cancer screening: behavioural risk factor surveillance system, 2002 and 2004. Ethn Dis 2010;20:359-65.
26. Etzioni DA, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer 2004;101:2523-32.
27. Fischer R, Collet T-H, Zeller A, et al. Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland. Eur J Cancer Prev 2013;22:425-30.
28. James TM, Greiner KA, Ellerbeck EF, et al. Disparities in colorectal cancer screening: A guideline-based analysis of adherence. Ethn Dis 2006;16:228-33.
29. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behaviour: A population-based study. Prev Med 2003;37:627-34.
30. Janz NK, Lakhani I, Vijan S, et al. Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med 2007;44:452-8.
31. Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 2008;168:1317-24.
32. Kendall KA, Lee E, Zuckerman IH, et al. Obesity status and colorectal cancer screening in the United States. J Obes 2013;2013:920270.
33. Klabunde CN, Meissner HI, Wooten KG, et al. Comparing colorectal cancer screening and immunization status in older americans. Am J Prev Med 2007;33:1-8.
34. Le RL, Eisinger F, Loundou A, et al. Sociogeographical factors associated with participation in colorectal cancer screening. Gastroenterol Clin Biol 2010;34:534-40.
35. Lemon S, Zapka J, Puleo E, et al. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001;91:1264-72.
36. Liang SY, Phillips KA, Nagamine M, et al. Rates and predictors of colorectal cancer screening. Prev Chronic Dis 2006;3:A117.
37. Martinez KA, Pollack CE, Phelan DF, et al. Gender differences in correlates of colorectal cancer screening among black Medicare beneficiaries in Baltimore. Cancer Epidemiol Biomarkers Prev 2013;22:1037-42.
38. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med 2005;165:2129-35.
39. Phillips KL, Smith ML, Ahn S, et al. Correlates of initiating colorectal cancer screening beginning at age 50. J Community Health 2013;38:23-30.
40. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A. Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterol 2007;7.
41. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviours. Am J Prev Med 2001;21:132-7.
42. Tastan S, Andsoy II, Iyigun E. Evaluation of the knowledge, behaviour and health beliefs of individuals over 50 regarding colorectal cancer screening. Asian Pac J Cancer Prev 2013;14:5157-63.
43. Walsh JME, Kaplan CP, Nguyen B, et al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans: compared with non-Latino white Americans. J Gen Intern Med 2004;19:156-66.
44. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med 2009;150:465-73.
45. Zhao BB, Kilbourne B, Stain SC, et al. Racial disparities and trends in use of colorectal procedures among Tennessee elderly (1996-2000). Ethn Dis 2006;16:412-20.
46. Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S. Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv Res 2006;6:116.
47. Zorzi M, Barca A, Falcini F, et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 2007;31(2-3 Suppl 2):49-60.
48. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive faecal occult blood test. Cancer Epidemiol Biomarkers Prev 2006; 15:1232-5.
49. Gonzalez P, Castaneda SF, Mills PJ, et al. Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women. J Commun Health 2012;37:421-33.
50. Griffith KA, McGuire DB, Royak-Schaler R, et al. Influence of family history and preventive health behaviours on colorectal cancer screening in African Americans. Cancer 2008;113:276-85.
51. Harewood GC, Wiersema MJ, Melton LJ, III. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002;97:3186-94.
52. Qumseya BJ, Tayem YI, Dasa OY, et al. Barriers to colorectal cancer screening in Palestine: A national study in a medically underserved population. Clin Gastroenterol Hepatol 2014;12:463-9.
53. Erban S, Zapka J, Puleo E, Vickers-Lahti M. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines. Eff Clin Pract 2001;4:10-7.
54. Almog R, Ezra G, Lavi I, et al. The public prefers faecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev 2008;17:430-7.
55. Pollack LA, Blackman DK, Wilson KM, et al. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis 2006;3:A50.
56. Salas D, Vanaclocha M, Ibanez J, et al. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control 2014;25:985-97.
57. Carlos RC, Underwood W III, Fendrick AM, Bernstein SJ. Behavioural associations between prostate and colon cancer screening. J Am Coll Surg 2005;200:216-23.
58. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
59. Wallace LS, Gupta R. Predictors of screening for breast and colorectal cancer among middle-aged women. Fam Med 2003;35:349-54.
60. Partin MR, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control 2010;21:1357-68.
61. Coughlin SS, Berkowitz Z, Hawkins NA, Tangka F. Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey. Prev Chronic Dis 2007;4:A57.
62. Duncan A, Turnbull D, Wilson C, et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: A population study. BMC Public Health 2014;14:238.
63. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082-91.
64. Mandelson MT, Curry SJ, Anderson LA, et al. Colorectal cancer screening participation by older women. Am J Prev Med 2000;19:149-54.
65. Jerant AF, Franks P, Jackson JE, Doescher MP. Age-related disparities in cancer screening: analysis of 2001 Behavioural Risk Factor Surveillance System data. Ann Fam Med 2004;2:481-7.
66. McGregor SE, Bryant HE. Predictors of colorectal cancer screening: A comparison of men and women. Can J Gastroenterol 2005;19:343-9.
67. Doubeni CA, Laiyemo AO, Reed G, et al. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 2009;18:2170-5.
68. Goel MS, Wee CC, McCarthy EP, et al. Racial and ethnic disparities in cancer screening: The importance of foreign birth as a barrier to care. J Gen Intern Med 2003;18:1028-35.
69. Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med 2006;30:320-6.
70. Walsh JME, Kim SE, Sawaya G, et al. Colorectal cancer screening: What do women from diverse ethnic groups want? J Gen Intern Med 2013;28:239-46.
71. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000;31:261-70.
72. Shenson D, Bolen J, Adams M, et al. Are older adults up-to-date with cancer screening and vaccinations? Prev Chronic Dis 2005;2:A04.
73. Wang JH, Liang W, Chen MY, et al. The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis 2006;16:404-11.
74. Johnson-Kozlow M Colorectal cancer screening of Californian adults of Mexican origin as a function of acculturation. J Immigr Minor Health 2009:1-8
75. Bostick RM, Sprafka JM, Virnig BA, Potter JD. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med 1994;23:816-26.
76. van Jaarsveld CH, Miles A, Edwards R, Wardle J. Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? J Med Screen 2006;13:172-6.
77. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health 2004;20:118-24.
78. Tabbarah M, Nowalk MP, Raymund M, et al. Barriers and facilitators of colon cancer screening among patients at faith-based neighborhood health centers. J Community Health 2005;30:55-74.
79. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med 2004;19:332-8.
80. Heo M, Allison DB, Fontaine KR. Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health 2004;4.
81. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-51.
82. So WK, Choi KC, Chan DN, et al. Colorectal cancer screening behaviour and associated factors among Chinese aged 50 and above in Hong Kong-A populationbased survey. Eur J Oncol Nurs 2012;16:413-8.
83. Dupont-Lucas C, Dejardin O, Dancourt V, et al. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test. Dig Liver Dis 2011;43:714-20.
84. Choi KS, Lee H-Y, Jun JK, et al. Adherence to follow-up after a positive faecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012;27:1070-7.
85. Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: A randomized trial. Ann Intern Med 2006 19;145:895-900.
86. Morris S, Baio G, Kendall E, Von WC, et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: A retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer 2012;107:765-71.
87. Paszat L, Rabeneck L, Kiefer L, et al. Endoscopic follow-up of positive faecal occult blood testing in the Ontario FOBT Project. Can J Gastroenterol 2007;21:379-82.
88. Turner B, Myers RE, Hyslop T, et al. Physician and patient factors associated with ordering a colon evaluation after a positive faecal occult blood test. J Gen Intern Med 2003;18:357-63.
89. Zheng YF, Saito T, Takahashi M, et al. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health 2006;6:272.
90. Becker MH, Maiman LA. Sociobehavioural determinants of compliance with health and medical care recommendations. Med Care 1975;13:10-24.
91. Hibbard JH, Pope CR. Another look at sex differences in the use of medical care: illness orientation and the types of morbidities for which services are used. Women Health 1986;11:21-36.
92. American Cancer Society Cancer Facts and Figures for African Americans. Atlanta: American Cancer Society, 2009.
93. American Cancer Society Cancer Facts and Figures. Atlanta: American Cancer Society, 2006.
94. Johnson-Kozlow M. Colorectal cancer screening of Californian adults of Mexican origin as a function of acculturation. J Immigr Minor Health 2010;12:454-61.
95. Haynes R, Pearce J, Barnett R. Cancer survival in New Zealand: ethnic, social and geographical inequalities. Soc Sci Med 2008;67:928-37.
96. Dejardin O, Bouvier AM, Faivre J, et al. Access to care, socioeconomic deprivation and colon cancer survival. Aliment Pharmacol Ther 2008;27:940-9.
97. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: The role of patient factors and physician counseling. Prev Med 2005;41:23-9.
98. Price JH. Perceptions of colorectal cancer in a socioeconomically disadvantaged population. J Commun Health 1993;18:347-62.
99. Ford JS, Coups EJ, Hay JL. Knowledge of colon cancer screening in a national probability sample in the United States. J Health Commun 2006;11(Suppl 1):19-35.
100. Winterich JA, Quandt SA, Grzywacz JG, et al. Men's knowledge and beliefs about colorectal cancer and 3 screenings: education, race, and screening status. Am J Health Behav 2011;35:525-34.
101. Bas K, Guler T, Gunay LM, et al. Public awareness of colorectal cancer in a Turkish population: importance of faecal occult blood testing. Asian Pac J Cancer Prev 2012;13:195-8.
102. Manne S, Markowitz A, Winawer S, et al. Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: A test of a mediational model. Prev Med 2003;36:71-84.
103. Denters MJ, Deutekom M, Bossuyt PM, et al. Patient burden of colonoscopy after positive faecal immunochemical testing for colorectal cancer screening. Endoscopy 2013;45:342-9.
104. Mitchell KA, Rawl SM, Champion VL, et al. Development and psychometric testing of the colonoscopy embarrassment scale. West J Nurs Res 2012;34:548-564.
105. McGregor S, Hilsden R, Yang H. Physician barriers to population-based, faecal occult blood test-based colorectal cancer screening programs for average-risk patients. Can J Gastroenterol 2010;24:359-64.
106. Nodora JN, Martz WD, Ashbeck EL, et al. Primary care physician compliance with colorectal cancer screening guidelines. Cancer Causes Control 2011;22:1277-87.
107. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993 7;85:566-70.